Skip to content

Abbott Rapid Diagnostics

Active Private limited companyfounded 1995active for 31 yearsDa Vincilaan 11, 1930 ZaventemKBO/BCE: BE 0455.002.056 subsidiary of
Part of the group 18 companies in 11 countries

Lifetime

19 annual accounts with figures on one time axis, 31 filings since 1995
peak €17.1m (2022)
€7.9m▼ 10.8%
peak €762,976 (2011)
€301,639▼ 5.0%
peak €7.1m (2025)
€7.1m▲ 4.5%
€867,242▼ 28.8%
peak 9.6 FTE (2013)
7.9 FTE▲ 14.5%
Board15 names since 2009all names
2 directors and 1 other
Owners8 names in the annual accountsall names
100% and 1 other
Documentsfilings and deeds
02-07-202629 days before the deadline
2025financial year
Staff from 6.9 FTE to 7.9 FTEPermanent representative: 20-05Debts from €1.2m to €867,242Cash from €924,253 to €592,595

Key points

from the 2025 annual accounts

Equity

€7.1m ▲ 4.5%

Abbott Rapid Diagnostics has made a profit in every financial year since 2007.

Staff

8 employees on 31-12-2025
012021212022112023012024312025

In 2025, 3 people joined and 1 left.

Payment terms

21 days to suppliers
Suppliers
31 to 21
Customers
83 to 68

Abbott Rapid Diagnostics pays its suppliers 10 days earlier than in 2024. Customers pay 15 days earlier.

Filings

31 annual accounts since 1995
AprilJune31 JulyOctober200020102020

The 2016 accounts came 100 days late. The other nine of the last ten were filed on time.

Board

1 joined · 1 left

Board changed. Latest change 01-01-2026 · 1 in office.

Position in the sector

89.1%

Higher solvency than 93% of companies in wholesale trade. Sector median 43.8% · 3,766 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,044 companies had the same profile as Abbott Rapid Diagnostics has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,044 companies, not a prediction for Abbott Rapid Diagnostics. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-01-2026
  • 100%score equity €2.10bn (2025) · annual accounts 2025
Board & ownership

Recent changes

Resignation: (director) Appointment: (director) · General meeting of 18-12-2025 · Gazette deed
Permanent representative: General meeting of 07-05-2025 · Gazette deed
Reappointment: (statutory auditor) General meeting of 28-06-2024 · Gazette deed
Publication in the Belgian Official Gazette Gazette deed
All 59 events

Comparable companies

same main activity, similar in size and age
Company
Abbott Rapid Diagnostics Zaventem €7.9m 3.7% 89.1% 7.9
ELEKTA Zaventem €13.9m 8.0% 21.0% 12.2
EPPENDORF BELGIUM Aarschot €7.1m 7.3% 31.9% 13.2
EISAI Leuven €7.6m 4.0% 65.1% 12.6
COGEZAF Gembloux €11.8m 4.4% 61.4% 5.3
Fedegari Europe Anderlecht €5.9m 23.1% 83.6% 15.1
INTEGRA LS (BENELUX) Ghent €7.1m 5.4% 87.0% 18.1
-10%0%10%20%€10m€100m€1bn€10bnAbbott Rapid DiagnosticsEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as Abbott Rapid Diagnostics: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €4.3m and €13m, founded between 1985 and 2007.

Official details

Source: KBO
Status
Active since 11-04-1995Normal situation
Registered office
11 active companies are registered at this addressSource: KBO register, as of 15 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2025
Establishment unit
2.071.403.9201930 Zaventem, since 28-04-1995
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€7.9m▼ 0.6%
Employeeson 31-12-2025
8▲ 33.3%
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on Abbott Rapid Diagnostics

Abbott Rapid Diagnostics has existed since 1995. Turnover grew from €4.7m in 2011 to €7.9m in 2025 and staff from 5.6 to 7.9 full-time equivalents.

Turnover has fallen every year since 2022.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Abbott Rapid Diagnostics

What is the company number of Abbott Rapid Diagnostics?
The company number of Abbott Rapid Diagnostics is 0455.002.056. The VAT number is the same number with BE in front: BE 0455.002.056.
Where is Abbott Rapid Diagnostics based?
The registered office is at Da Vincilaan 11, 1930 Zaventem.Company details
What does Abbott Rapid Diagnostics do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Abbott Rapid Diagnostics?
Abbott Rapid Diagnostics is a private limited company (BV).
When was Abbott Rapid Diagnostics founded?
Abbott Rapid Diagnostics was founded on 11-04-1995.
Is Abbott Rapid Diagnostics still active?
Yes, Abbott Rapid Diagnostics is an active enterprise in the KBO register.
How many employees does Abbott Rapid Diagnostics have?
Abbott Rapid Diagnostics had an average of 7.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Abbott Rapid Diagnostics fall under?
In its 2025 annual accounts, Abbott Rapid Diagnostics states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of Abbott Rapid Diagnostics?
The turnover of Abbott Rapid Diagnostics was €7.9m in financial year 2025, according to the filed annual accounts.
Is Abbott Rapid Diagnostics profitable?
In financial year 2025, Abbott Rapid Diagnostics made a profit of €301,639.
Where can I find the annual accounts of Abbott Rapid Diagnostics?
Abbott Rapid Diagnostics filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Abbott Rapid Diagnostics due?
Abbott Rapid Diagnostics must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.